HEADER HYDROLASE/HYDROLASE INHIBITOR 20-AUG-01 1GKT TITLE NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TITLE 2 TRANSITION STATE ANALOGUE INHIBITOR H261 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.22; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INHIBITOR, H261; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 8 ORGANISM_TAXID: 32630 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASE-INHIBITOR, ASPARTIC KEYWDS 2 PROTEINASE, HYDROLYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX EXPDTA NEUTRON DIFFRACTION AUTHOR L.COATES,P.T.ERSKINE,S.P.WOOD,D.A.A.MYLES,J.B.COOPER REVDAT 8 15-NOV-23 1GKT 1 LINK ATOM REVDAT 7 14-FEB-18 1GKT 1 REMARK REVDAT 6 22-MAR-17 1GKT 1 REMARK ATOM REVDAT 5 16-JAN-13 1GKT 1 REMARK ATOM HETATM MASTER REVDAT 4 13-JUL-11 1GKT 1 VERSN REVDAT 3 24-FEB-09 1GKT 1 VERSN REVDAT 2 24-JUN-03 1GKT 1 MODRES HET ATOM HETATM REVDAT 2 2 1 CONECT REVDAT 1 20-NOV-01 1GKT 0 JRNL AUTH L.COATES,P.T.ERSKINE,S.P.WOOD,D.A.A.MYLES,J.B.COOPER JRNL TITL A NEUTRON LAUE DIFFRACTION STUDY OF ENDOTHIAPEPSIN: JRNL TITL 2 IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM JRNL REF BIOCHEMISTRY V. 40 13149 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11683623 JRNL DOI 10.1021/BI010626H REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.0 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.235 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 687 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 13548 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.234 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 679 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 13427 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2467 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 255 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 20487 REMARK 3 NUMBER OF RESTRAINTS : 97252 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.014 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.023 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.023 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.027 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.051 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GKT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1290008415. REMARK 230 REMARK 230 EXPERIMENTAL DETAILS REMARK 230 EXPERIMENT TYPE : NEUTRON DIFFRACTION REMARK 230 DATE OF DATA COLLECTION : 01-NOV-99 REMARK 230 TEMPERATURE (KELVIN) : 293.0 REMARK 230 PH : 4.50 REMARK 230 NUMBER OF CRYSTALS USED : 2 REMARK 230 REMARK 230 NEUTRON SOURCE : NUCLEAR REACTOR REMARK 230 BEAMLINE : LADI REMARK 230 WAVELENGTH OR RANGE (A) : 2.7-3.6 REMARK 230 MONOCHROMATOR : NULL REMARK 230 OPTICS : NULL REMARK 230 REMARK 230 DETECTOR TYPE : IMAGE PLATE REMARK 230 DETECTOR MANUFACTURER : NULL REMARK 230 INTENSITY-INTEGRATION SOFTWARE : LAUEGEN REMARK 230 DATA SCALING SOFTWARE : SCALA REMARK 230 REMARK 230 NUMBER OF UNIQUE REFLECTIONS : 13548 REMARK 230 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 230 RESOLUTION RANGE LOW (A) : 20.000 REMARK 230 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 230 REMARK 230 OVERALL. REMARK 230 COMPLETENESS FOR RANGE (%) : 85.0 REMARK 230 DATA REDUNDANCY : 3.400 REMARK 230 R MERGE (I) : 0.07500 REMARK 230 R SYM (I) : 0.07500 REMARK 230 FOR THE DATA SET : 5.4000 REMARK 230 REMARK 230 IN THE HIGHEST RESOLUTION SHELL. REMARK 230 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 230 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 230 COMPLETENESS FOR SHELL (%) : 72.6 REMARK 230 DATA REDUNDANCY IN SHELL : 2.40 REMARK 230 R MERGE FOR SHELL (I) : 0.11900 REMARK 230 R SYM FOR SHELL (I) : NULL REMARK 230 FOR SHELL : 1.700 REMARK 230 REMARK 230 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 230 SOFTWARE USED : NULL REMARK 230 STARTING MODEL: NULL REMARK 230 REMARK 230 REMARK: HYDROGEN/DEUTERIUM EXCHANGE BY CAPILLARY VAPOUR DIFFUSION. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AS FOR 2ER7, PH 4.5, PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.85000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE H-261 OLIGOPEPTIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: H-261 OLIGOPEPTIDE REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 DG SER A 95 HG1 THR A 100 0.60 REMARK 500 HE21 GLN A 56 O ASP A 119 1.01 REMARK 500 OG SER A 95 HG1 THR A 100 1.20 REMARK 500 H THR A 139 O HOH A 2144 1.25 REMARK 500 HH TYR A 179 O DOD A 2171 1.28 REMARK 500 O GLY A 201 H GLY A 265 1.29 REMARK 500 H THR A 208 O HOH A 2195 1.33 REMARK 500 H ALA A 187 O HOH A 2181 1.35 REMARK 500 H THR A 321 O HOH A 2243 1.39 REMARK 500 H SER A 245 O GLY A 250 1.41 REMARK 500 HG1 THR A 91 O HOH A 2109 1.43 REMARK 500 HH21 ARG A 270 O HOH A 2225 1.44 REMARK 500 H LYS A 68 O THR A 91 1.45 REMARK 500 DG SER A 95 OG1 THR A 100 1.45 REMARK 500 O LEU A 41 H GLU A 107 1.47 REMARK 500 O PHE A 262 H ILE A 273 1.48 REMARK 500 OE2 GLU A 52 H VAL A 112 1.49 REMARK 500 O VAL A 156 H GLY A 172 1.50 REMARK 500 OE1 GLU A 47 DH TYR A 90 1.50 REMARK 500 HE21 GLN A 192 OE2 GLU A 196 1.51 REMARK 500 O ALA A 50 H VAL A 53 1.51 REMARK 500 O GLU A 52 DG1 THR A 117 1.51 REMARK 500 O PHE A 44 H TYR A 59 1.51 REMARK 500 H PHE A 314 O ALA A 328 1.51 REMARK 500 O TYR A 90 H VAL A 106 1.53 REMARK 500 H ASP A 160 O THR A 168 1.53 REMARK 500 O SER A 154 H VAL A 156 1.55 REMARK 500 O THR A 8 H ILE A 18 1.56 REMARK 500 O ASP A 88 H SER A 108 1.56 REMARK 500 O VAL A 94 H VAL A 101 1.56 REMARK 500 OD2 ASP A 175 DG1 THR A 177 1.56 REMARK 500 DG1 THR A 25 OG1 THR A 66 1.57 REMARK 500 O VAL A 316 H GLY A 326 1.57 REMARK 500 H SER A 189 O GLU A 196 1.58 REMARK 500 H THR A 57 OD1 ASP A 123 1.58 REMARK 500 O PHE A 116 H ASP A 119 1.60 REMARK 500 NE2 GLN A 56 O ASP A 119 1.98 REMARK 500 O HOH B 2001 O HOH B 2002 2.05 REMARK 500 O HOH A 2065 O HOH A 2134 2.09 REMARK 500 O SER A 46 O HOH A 2069 2.12 REMARK 500 O ALA A 73 O HOH A 2101 2.16 REMARK 500 OD1 ASP A 153 O HOH A 2155 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HG SER A 288 O HIS B 407 2546 1.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SUI A 54 CA - C - N ANGL. DEV. = -42.0 DEGREES REMARK 500 LOV B 405 CA - C - N ANGL. DEV. = 20.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 45.34 -141.20 REMARK 500 ALA A 67 122.78 -34.26 REMARK 500 LEU A 70 93.63 -62.32 REMARK 500 ASP A 160 70.67 -112.48 REMARK 500 THR A 176 3.77 -68.35 REMARK 500 ALA A 187 150.72 -41.13 REMARK 500 PHE A 253 145.68 -174.40 REMARK 500 ASP A 279 85.28 -61.46 REMARK 500 ILE A 302 118.92 178.93 REMARK 500 ALA A 320 172.24 -56.72 REMARK 500 HIS B 404 81.78 -152.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LOV B 405 ILE B 406 -99.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SUI A 54 12.30 REMARK 500 LOV B 405 42.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2001 DISTANCE = 8.08 ANGSTROMS REMARK 525 HOH A2002 DISTANCE = 7.90 ANGSTROMS REMARK 525 HOH A2004 DISTANCE = 6.42 ANGSTROMS REMARK 525 HOH A2005 DISTANCE = 6.97 ANGSTROMS REMARK 525 HOH A2006 DISTANCE = 8.13 ANGSTROMS REMARK 525 HOH A2011 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH A2012 DISTANCE = 6.32 ANGSTROMS REMARK 525 HOH A2013 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH A2014 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A2017 DISTANCE = 8.94 ANGSTROMS REMARK 525 HOH A2022 DISTANCE = 8.08 ANGSTROMS REMARK 525 HOH A2026 DISTANCE = 6.75 ANGSTROMS REMARK 525 HOH A2027 DISTANCE = 8.24 ANGSTROMS REMARK 525 HOH A2030 DISTANCE = 6.09 ANGSTROMS REMARK 525 HOH A2036 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A2041 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH A2044 DISTANCE = 6.98 ANGSTROMS REMARK 525 HOH A2053 DISTANCE = 7.01 ANGSTROMS REMARK 525 HOH A2058 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH A2065 DISTANCE = 6.98 ANGSTROMS REMARK 525 HOH A2072 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH A2090 DISTANCE = 7.08 ANGSTROMS REMARK 525 HOH A2093 DISTANCE = 7.31 ANGSTROMS REMARK 525 HOH A2095 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH A2106 DISTANCE = 6.24 ANGSTROMS REMARK 525 HOH A2107 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH A2112 DISTANCE = 6.73 ANGSTROMS REMARK 525 HOH A2134 DISTANCE = 6.37 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF INHIBITOR, H261 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E5O RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 REMARK 900 RELATED ID: 1E80 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD56133 REMARK 900 RELATED ID: 1E81 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD61395 REMARK 900 RELATED ID: 1E82 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD59601 REMARK 900 RELATED ID: 1EED RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE CYCLOHEXYL RENIN INHIBITOR PD125754 REMARK 900 RELATED ID: 1ENT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE INHIBITOR PD130328 REMARK 900 RELATED ID: 1EPL RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH PS1 PRO LEU GLU PSA ARG LEU REMARK 900 RELATED ID: 1EPM RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH PS2 THR PHE GLN ALA PSA LEU ARG GLU REMARK 900 RELATED ID: 1EPN RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH CP-80,794 MOR PHE CYS+CH3 NOR REMARK 900 RELATED ID: 1EPO RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH CP-81,282 MOR PHE NLE CHF NME REMARK 900 RELATED ID: 1EPP RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH PD-130,693 MAS PHE LYS+MTF STA MBA REMARK 900 RELATED ID: 1EPQ RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH PD-133,450 SOT PHE GLY+SCC GCL REMARK 900 RELATED ID: 1EPR RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.22) REMARK 900 COMPLEXED WITH PD-135,040 TSM DPH HIS CHF EMR REMARK 900 RELATED ID: 1ER8 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH H-77 REMARK 900 RELATED ID: 2ER0 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH L364,099 REMARK 900 RELATED ID: 2ER6 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH H-256 REMARK 900 RELATED ID: 2ER7 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH H-261 REMARK 900 RELATED ID: 2ER9 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH L363,564 REMARK 900 RELATED ID: 3ER3 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH CP-71,362 REMARK 900 RELATED ID: 3ER5 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) H-189 REMARK 900 COMPLEX REMARK 900 RELATED ID: 4APE RELATED DB: PDB REMARK 900 ACID PROTEINASE (E.C.3.4.23.10), ENDOTHIAPEPSIN REMARK 900 RELATED ID: 4ER1 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH PD125967 REMARK 900 RELATED ID: 4ER2 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH PEPSTATIN REMARK 900 RELATED ID: 4ER4 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) H-142 REMARK 900 COMPLEX REMARK 900 RELATED ID: 5ER1 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) BW624 REMARK 900 COMPLEX REMARK 900 RELATED ID: 5ER2 RELATED DB: PDB REMARK 900 ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) (E.C.3.4.23.6) REMARK 900 COMPLEX WITH CP-69,799 DBREF 1GKT A 1 330 UNP P11838 CARP_CRYPA 90 419 DBREF 1GKT B 400 407 PDB 1GKT 1GKT 400 407 SEQRES 1 A 329 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 329 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 329 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 329 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 329 VAL SUI GLN THR ILE TYR THR PRO SER LYS SER THR THR SEQRES 6 A 329 ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER TYR SEQRES 7 A 329 GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR ASP SEQRES 8 A 329 THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN ALA SEQRES 9 A 329 VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR GLU SEQRES 10 A 329 ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SER SEQRES 11 A 329 THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR PHE SEQRES 12 A 329 PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL PHE SEQRES 13 A 329 THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR ASN SEQRES 14 A 329 PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER ILE SEQRES 15 A 329 THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP GLU SEQRES 16 A 329 TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR PHE SEQRES 17 A 329 LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY THR SEQRES 18 A 329 THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA TYR SEQRES 19 A 329 TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER VAL SEQRES 20 A 329 GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SER SEQRES 21 A 329 PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE PRO SEQRES 22 A 329 GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SER SEQRES 23 A 329 SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY ILE SEQRES 24 A 329 GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA ALA SEQRES 25 A 329 PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU GLY SEQRES 26 A 329 PHE ALA SER LYS SEQRES 1 B 8 BOC HIS PRO PHE HIS LOV ILE HIS MODRES 1GKT SUI A 54 ASP MODRES 1GKT SUI A 54 GLY HET SUI A 54 17 HET BOC B 400 16 HET LOV B 405 38 HETNAM SUI (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID HETNAM BOC TERT-BUTYL HYDROGEN CARBONATE HETNAM LOV 5-AMINO-4-HYDROXY-2-ISOPROPYL-7-METHYL-OCTANOIC ACID FORMUL 1 SUI C6 H8 N2 O4 FORMUL 2 BOC C5 H10 O3 FORMUL 2 LOV C12 H25 N O3 FORMUL 3 HOH *255(H2 O) HELIX 1 1 THR A 49 VAL A 53 5 5 HELIX 2 2 THR A 60 SER A 64 5 5 HELIX 3 3 SER A 113 GLU A 118 1 6 HELIX 4 4 PHE A 130 ASN A 134 5 5 HELIX 5 5 THR A 143 LYS A 149 1 7 HELIX 6 6 ALA A 150 LEU A 152 5 3 HELIX 7 7 PRO A 228 ALA A 237 1 10 HELIX 8 8 PRO A 274 ILE A 278 1 5 HELIX 9 9 GLY A 306 LYS A 311 1 6 SHEET 1 AA 3 LYS A 68 SER A 78 0 SHEET 2 AA 3 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AA 3 TYR A 17 ILE A 23 -1 O GLN A 22 N SER A 95 SHEET 1 AB 7 LYS A 68 SER A 78 0 SHEET 2 AB 7 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AB 7 LEU A 99 VAL A 112 -1 O LEU A 99 N VAL A 96 SHEET 4 AB 7 LEU A 41 PHE A 44 1 O LEU A 41 N GLU A 107 SHEET 5 AB 7 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AB 7 GLN A 28 ASP A 35 1 O ASP A 33 N LEU A 126 SHEET 7 AB 7 TYR A 17 ILE A 23 -1 O THR A 19 N LEU A 32 SHEET 1 AC 7 ALA A 269 ILE A 273 0 SHEET 2 AC 7 PHE A 262 VAL A 266 -1 O PHE A 262 N ILE A 273 SHEET 3 AC 7 GLU A 196 VAL A 204 -1 O GLY A 201 N GLY A 265 SHEET 4 AC 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AC 7 ASN A 303 PHE A 305 1 O ASN A 303 N ILE A 217 SHEET 6 AC 7 LEU A 225 LEU A 227 -1 O TYR A 226 N ILE A 304 SHEET 7 AC 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 227 SHEET 1 AD 4 LYS A 243 SER A 245 0 SHEET 2 AD 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AD 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AD 4 ASP A 279 PRO A 282 -1 O GLY A 281 N PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.03 LINK C VAL A 53 N SUI A 54 1555 1555 1.33 LINK C SUI A 54 N GLN A 56 1555 1555 1.33 LINK C BOC B 400 N HIS B 401 1555 1555 1.33 LINK C HIS B 404 N LOV B 405 1555 1555 1.33 LINK C LOV B 405 N ILE B 406 1555 1555 1.33 CISPEP 1 THR A 25 PRO A 26 0 -0.69 CISPEP 2 SER A 137 PRO A 138 0 0.14 SITE 1 AC1 25 ILE A 10 ASP A 15 ASP A 35 GLY A 37 SITE 2 AC1 25 SER A 78 TYR A 79 GLY A 80 ASP A 81 SITE 3 AC1 25 ASP A 119 ILE A 122 LEU A 125 LEU A 133 SITE 4 AC1 25 ILE A 217 ASP A 219 GLY A 221 THR A 222 SITE 5 AC1 25 THR A 223 PHE A 280 GLY A 281 PRO A 282 SITE 6 AC1 25 ILE A 300 ILE A 304 HOH A2051 HOH A2103 SITE 7 AC1 25 HOH B2003 CRYST1 43.100 75.700 42.900 90.00 97.00 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023202 0.000000 0.002849 0.00000 SCALE2 0.000000 0.013210 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023485 0.00000